Bleeding Disorders Market, Global Outlook and Forecast 2022-2028

April 2022 | 64 pages | ID: B3D4EB1806EAEN
Market Monitor Global

Abstracts

The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.

This report contains market size and forecasts of Bleeding Disorders in Global, including the following market information:

Global Bleeding Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bleeding Disorders market was valued at 11130 million in 2021 and is projected to reach US$ 16870 million by 2028, at a CAGR of 6.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Plasma-derived Coagulation Factor Concentrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bleeding Disorders include Novo Nordisk, Bayer, Baxter International, Alnylam Pharmaceuticals, Pfizer, Xenetic Biosciences, Bristol-Myers Squibb Company, Sanofi and Janssen Global Services, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bleeding Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bleeding Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bleeding Disorders Market Segment Percentages, by Type, 2021 (%)

• Plasma-derived Coagulation Factor Concentrates
• Recombinant Coagulation Factor Concentrates
• Desmopressin
• Antifibrinolytics
• Fibrin Sealants
• Others

Global Bleeding Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bleeding Disorders Market Segment Percentages, by Application, 2021 (%)

• Hemophilia A
• Hemophilia B
• Others

Global Bleeding Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bleeding Disorders Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bleeding Disorders revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bleeding Disorders revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Bayer
• Baxter International
• Alnylam Pharmaceuticals
• Pfizer
• Xenetic Biosciences
• Bristol-Myers Squibb Company
• Sanofi
• Janssen Global Services
• Bioverativ
• Amgen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bleeding Disorders Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bleeding Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLEEDING DISORDERS OVERALL MARKET SIZE

2.1 Global Bleeding Disorders Market Size: 2021 VS 2028
2.2 Global Bleeding Disorders Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bleeding Disorders Players in Global Market
3.2 Top Global Bleeding Disorders Companies Ranked by Revenue
3.3 Global Bleeding Disorders Revenue by Companies
3.4 Top 3 and Top 5 Bleeding Disorders Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bleeding Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bleeding Disorders Players in Global Market
  3.6.1 List of Global Tier 1 Bleeding Disorders Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bleeding Disorders Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bleeding Disorders Market Size Markets, 2021 & 2028
  4.1.2 Plasma-derived Coagulation Factor Concentrates
  4.1.3 Recombinant Coagulation Factor Concentrates
  4.1.4 Desmopressin
  4.1.5 Antifibrinolytics
  4.1.6 Fibrin Sealants
  4.1.7 Others
4.2 By Type - Global Bleeding Disorders Revenue & Forecasts
  4.2.1 By Type - Global Bleeding Disorders Revenue, 2017-2022
  4.2.2 By Type - Global Bleeding Disorders Revenue, 2023-2028
  4.2.3 By Type - Global Bleeding Disorders Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bleeding Disorders Market Size, 2021 & 2028
  5.1.2 Hemophilia A
  5.1.3 Hemophilia B
  5.1.4 Others
5.2 By Application - Global Bleeding Disorders Revenue & Forecasts
  5.2.1 By Application - Global Bleeding Disorders Revenue, 2017-2022
  5.2.2 By Application - Global Bleeding Disorders Revenue, 2023-2028
  5.2.3 By Application - Global Bleeding Disorders Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bleeding Disorders Market Size, 2021 & 2028
6.2 By Region - Global Bleeding Disorders Revenue & Forecasts
  6.2.1 By Region - Global Bleeding Disorders Revenue, 2017-2022
  6.2.2 By Region - Global Bleeding Disorders Revenue, 2023-2028
  6.2.3 By Region - Global Bleeding Disorders Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bleeding Disorders Revenue, 2017-2028
  6.3.2 US Bleeding Disorders Market Size, 2017-2028
  6.3.3 Canada Bleeding Disorders Market Size, 2017-2028
  6.3.4 Mexico Bleeding Disorders Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bleeding Disorders Revenue, 2017-2028
  6.4.2 Germany Bleeding Disorders Market Size, 2017-2028
  6.4.3 France Bleeding Disorders Market Size, 2017-2028
  6.4.4 U.K. Bleeding Disorders Market Size, 2017-2028
  6.4.5 Italy Bleeding Disorders Market Size, 2017-2028
  6.4.6 Russia Bleeding Disorders Market Size, 2017-2028
  6.4.7 Nordic Countries Bleeding Disorders Market Size, 2017-2028
  6.4.8 Benelux Bleeding Disorders Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bleeding Disorders Revenue, 2017-2028
  6.5.2 China Bleeding Disorders Market Size, 2017-2028
  6.5.3 Japan Bleeding Disorders Market Size, 2017-2028
  6.5.4 South Korea Bleeding Disorders Market Size, 2017-2028
  6.5.5 Southeast Asia Bleeding Disorders Market Size, 2017-2028
  6.5.6 India Bleeding Disorders Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bleeding Disorders Revenue, 2017-2028
  6.6.2 Brazil Bleeding Disorders Market Size, 2017-2028
  6.6.3 Argentina Bleeding Disorders Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bleeding Disorders Revenue, 2017-2028
  6.7.2 Turkey Bleeding Disorders Market Size, 2017-2028
  6.7.3 Israel Bleeding Disorders Market Size, 2017-2028
  6.7.4 Saudi Arabia Bleeding Disorders Market Size, 2017-2028
  6.7.5 UAE Bleeding Disorders Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Corporate Summary
  7.1.2 Novo Nordisk Business Overview
  7.1.3 Novo Nordisk Bleeding Disorders Major Product Offerings
  7.1.4 Novo Nordisk Bleeding Disorders Revenue in Global Market (2017-2022)
  7.1.5 Novo Nordisk Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Bleeding Disorders Major Product Offerings
  7.2.4 Bayer Bleeding Disorders Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Baxter International
  7.3.1 Baxter International Corporate Summary
  7.3.2 Baxter International Business Overview
  7.3.3 Baxter International Bleeding Disorders Major Product Offerings
  7.3.4 Baxter International Bleeding Disorders Revenue in Global Market (2017-2022)
  7.3.5 Baxter International Key News
7.4 Alnylam Pharmaceuticals
  7.4.1 Alnylam Pharmaceuticals Corporate Summary
  7.4.2 Alnylam Pharmaceuticals Business Overview
  7.4.3 Alnylam Pharmaceuticals Bleeding Disorders Major Product Offerings
  7.4.4 Alnylam Pharmaceuticals Bleeding Disorders Revenue in Global Market (2017-2022)
  7.4.5 Alnylam Pharmaceuticals Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Bleeding Disorders Major Product Offerings
  7.5.4 Pfizer Bleeding Disorders Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Xenetic Biosciences
  7.6.1 Xenetic Biosciences Corporate Summary
  7.6.2 Xenetic Biosciences Business Overview
  7.6.3 Xenetic Biosciences Bleeding Disorders Major Product Offerings
  7.6.4 Xenetic Biosciences Bleeding Disorders Revenue in Global Market (2017-2022)
  7.6.5 Xenetic Biosciences Key News
7.7 Bristol-Myers Squibb Company
  7.7.1 Bristol-Myers Squibb Company Corporate Summary
  7.7.2 Bristol-Myers Squibb Company Business Overview
  7.7.3 Bristol-Myers Squibb Company Bleeding Disorders Major Product Offerings
  7.7.4 Bristol-Myers Squibb Company Bleeding Disorders Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Company Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Bleeding Disorders Major Product Offerings
  7.8.4 Sanofi Bleeding Disorders Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Janssen Global Services
  7.9.1 Janssen Global Services Corporate Summary
  7.9.2 Janssen Global Services Business Overview
  7.9.3 Janssen Global Services Bleeding Disorders Major Product Offerings
  7.9.4 Janssen Global Services Bleeding Disorders Revenue in Global Market (2017-2022)
  7.9.5 Janssen Global Services Key News
7.10 Bioverativ
  7.10.1 Bioverativ Corporate Summary
  7.10.2 Bioverativ Business Overview
  7.10.3 Bioverativ Bleeding Disorders Major Product Offerings
  7.10.4 Bioverativ Bleeding Disorders Revenue in Global Market (2017-2022)
  7.10.5 Bioverativ Key News
7.11 Amgen
  7.11.1 Amgen Corporate Summary
  7.11.2 Amgen Business Overview
  7.11.3 Amgen Bleeding Disorders Major Product Offerings
  7.11.4 Amgen Bleeding Disorders Revenue in Global Market (2017-2022)
  7.11.5 Amgen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bleeding Disorders Market Opportunities & Trends in Global Market
Table 2. Bleeding Disorders Market Drivers in Global Market
Table 3. Bleeding Disorders Market Restraints in Global Market
Table 4. Key Players of Bleeding Disorders in Global Market
Table 5. Top Bleeding Disorders Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bleeding Disorders Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bleeding Disorders Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bleeding Disorders Product Type
Table 9. List of Global Tier 1 Bleeding Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bleeding Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bleeding Disorders Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bleeding Disorders Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bleeding Disorders Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bleeding Disorders Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bleeding Disorders Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bleeding Disorders Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bleeding Disorders Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bleeding Disorders Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bleeding Disorders Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bleeding Disorders Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bleeding Disorders Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bleeding Disorders Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bleeding Disorders Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bleeding Disorders Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bleeding Disorders Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bleeding Disorders Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bleeding Disorders Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bleeding Disorders Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bleeding Disorders Revenue, (US$, Mn), 2023-2028
Table 30. Novo Nordisk Corporate Summary
Table 31. Novo Nordisk Bleeding Disorders Product Offerings
Table 32. Novo Nordisk Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Bleeding Disorders Product Offerings
Table 35. Bayer Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 36. Baxter International Corporate Summary
Table 37. Baxter International Bleeding Disorders Product Offerings
Table 38. Baxter International Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 39. Alnylam Pharmaceuticals Corporate Summary
Table 40. Alnylam Pharmaceuticals Bleeding Disorders Product Offerings
Table 41. Alnylam Pharmaceuticals Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Bleeding Disorders Product Offerings
Table 44. Pfizer Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 45. Xenetic Biosciences Corporate Summary
Table 46. Xenetic Biosciences Bleeding Disorders Product Offerings
Table 47. Xenetic Biosciences Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Company Corporate Summary
Table 49. Bristol-Myers Squibb Company Bleeding Disorders Product Offerings
Table 50. Bristol-Myers Squibb Company Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Bleeding Disorders Product Offerings
Table 53. Sanofi Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 54. Janssen Global Services Corporate Summary
Table 55. Janssen Global Services Bleeding Disorders Product Offerings
Table 56. Janssen Global Services Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 57. Bioverativ Corporate Summary
Table 58. Bioverativ Bleeding Disorders Product Offerings
Table 59. Bioverativ Bleeding Disorders Revenue (US$, Mn), (2017-2022)
Table 60. Amgen Corporate Summary
Table 61. Amgen Bleeding Disorders Product Offerings
Table 62. Amgen Bleeding Disorders Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bleeding Disorders Segment by Type in 2021
Figure 2. Bleeding Disorders Segment by Application in 2021
Figure 3. Global Bleeding Disorders Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bleeding Disorders Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bleeding Disorders Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bleeding Disorders Revenue in 2021
Figure 8. By Type - Global Bleeding Disorders Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bleeding Disorders Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bleeding Disorders Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bleeding Disorders Revenue Market Share, 2017-2028
Figure 12. US Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bleeding Disorders Revenue Market Share, 2017-2028
Figure 16. Germany Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 17. France Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bleeding Disorders Revenue Market Share, 2017-2028
Figure 24. China Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 28. India Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bleeding Disorders Revenue Market Share, 2017-2028
Figure 30. Brazil Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bleeding Disorders Revenue Market Share, 2017-2028
Figure 33. Turkey Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bleeding Disorders Revenue, (US$, Mn), 2017-2028
Figure 37. Novo Nordisk Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxter International Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alnylam Pharmaceuticals Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Xenetic Biosciences Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Company Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Janssen Global Services Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bioverativ Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Amgen Bleeding Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)